Skip to content
10-Q

Quarterly Report

BIO-TECHNE Corp TECH

0001558370-25-006990

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · May 1, 2025 156.77M sh
Short Term Investments Q3 2025 · Mar 31, 2025 $0
Short Term Investments Q3 2025 · Jun 30, 2024 $1.07M
Cash And Equivalents Q3 2025 · Mar 31, 2025 $140.67M
Cash And Equivalents Q3 2025 · Jun 30, 2024 $151.79M
Stockholders Equity Q3 2025 · Mar 31, 2025 $2.02B
Stockholders Equity Q3 2025 · Dec 31, 2024 $2.08B
Stockholders Equity Q3 2025 · Sep 30, 2024 $2.14B
Stockholders Equity Q3 2025 · Jun 30, 2024 $2.07B
Stockholders Equity Q3 2025 · Mar 31, 2024 $2.01B
Stockholders Equity Q3 2025 · Dec 31, 2023 $1.96B
Stockholders Equity Q3 2025 · Sep 30, 2023 $2B
Stockholders Equity Q3 2025 · Jun 30, 2023 $1.97B
Current Liabilities Q3 2025 · Mar 31, 2025 $169.2M
Current Liabilities Q3 2025 · Jun 30, 2024 $159.38M
Current Assets Q3 2025 · Mar 31, 2025 $627.24M
Current Assets Q3 2025 · Jun 30, 2024 $617.42M
Total Assets Q3 2025 · Mar 31, 2025 $2.64B
Total Assets Q3 2025 · Jun 30, 2024 $2.7B
Shares Diluted Q3 2025 · Mar 31, 2024 160.5M sh
Shares Diluted Q3 2025 · Mar 31, 2024 160.82M sh
Stock Repurchased Q3 2025 · Mar 31, 2024 $80.04M
Dividends Paid Q3 2025 · Mar 31, 2024 $37.79M
Capex Q3 2025 · Mar 31, 2024 $44.9M
Operating Cash Flow Q3 2025 · Mar 31, 2024 $223.49M
Eps Diluted Q3 2025 · Mar 31, 2024 $0.31
Eps Diluted Q3 2025 · Mar 31, 2024 $0.79
Eps Basic Q3 2025 · Mar 31, 2024 $0.31
Eps Basic Q3 2025 · Mar 31, 2024 $0.81
Sga Expense Q3 2025 · Mar 31, 2024 $111.84M
Sga Expense Q3 2025 · Mar 31, 2024 $332.84M
Net Income Q3 2025 · Mar 31, 2024 $49.06M
Net Income Q3 2025 · Mar 31, 2024 $127.52M
Operating Income Q3 2025 · Mar 31, 2024 $67M
Operating Income Q3 2025 · Mar 31, 2024 $160.86M
Gross Profit Q3 2025 · Mar 31, 2024 $204.6M
Gross Profit Q3 2025 · Mar 31, 2024 $566.38M
Cost Of Revenue Q3 2025 · Mar 31, 2024 $98.83M
Cost Of Revenue Q3 2025 · Mar 31, 2024 $286.58M
Revenue Q3 2025 · Mar 31, 2024 $303.43M
Revenue Q3 2025 · Mar 31, 2024 $852.96M